Identifying people at a high risk of developing pancreatic cancer (original) (raw)

• Howlader, N. et al. SEER Cancer Statistics Review, 1975–2005. National Cancer Institute, [online] (2010).
• Cleary, S. P. et al. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J. Am. Coll. Surg. 198, 722–731 (2004).
  Article Google Scholar
• Klein, A. P. et al. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res. 64, 2634–2638 (2004). This study quantified the risk of pancreatic cancer among individuals with a strong family history of the disease paving the way for gene discovery and screening studies.
  Article CAS Google Scholar
• Brune, K. A. et al. Importance of age of onset in pancreatic cancer kindreds. J. Natl Cancer Inst. 102, 119–126 (2010).
  Article Google Scholar
• Goggins, M. et al. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res. 56, 5360–5364 (1996).
  CAS PubMed Google Scholar
• Jones, S. et al. Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 324, 217 (2009). This was the first identification of a cause of a hereditary disease using exome sequencing and also demonstrated mutations in PALB2 at increased frequency in patients with familial pancreatic cancer.
  Article CAS Google Scholar
• Roberts, N. J. et al. ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov. 2, 41–46 (2012). This study used exome and whole-genome sequencing to show that mutations in the ATM gene were at an increased frequency in patients with familial pancreatic cancer.
  Article CAS Google Scholar
• Warthin, A. S. Heredity with reference to carcinoma. Arch. Intern. Med. 12, 546–555 (1913). This is a historical study of the power of studying cancer.
  Article Google Scholar
• Douglas, J. A. et al. History and molecular genetics of Lynch syndrome in family G: a century later. JAMA 294, 2195–2202 (2005).
  Article CAS Google Scholar
• MacDermott, R. P. & Kramer, P. Adenocarcinoma of the pancreas in four siblings. Gastroenterology 65, 137–139 (1973).
  CAS PubMed Google Scholar
• Friedman, J. M. & Fialkow, P. J. Carcinoma of the pancreas in four brothers. Birth Defects Orig. Artic. Ser. 12, 145–150 (1976).
  CAS PubMed Google Scholar
• Reimer, R. R., Fraumeni, J. F. Jr, Ozols, R. F. & Bender, R. Pancreatic cancer in father and son. Lancet 1, 911 (1977).
  Article CAS Google Scholar
• Danes, B. S. & Lynch, H. T. A familial aggregation of pancreatic cancer. An in vitro study. JAMA 247, 2798–2802 (1982).
  Article CAS Google Scholar
• Dat, N. M. & Sontag, S. J. Pancreatic carcinoma in brothers. Ann.Intern.Med. 97, 282 (1982).
  Article CAS Google Scholar
• Katkhouda, N. & Mouiel, J. Pancreatic cancer in mother and daughter. Lancet 2, 747 (1986).
  Article CAS Google Scholar
• Ghadirian, P., Simard, A. & Baillargeon, J. Cancer of the pancreas in two brothers and one sister. Int. J. Pancreatol. 2, 383–391 (1987).
  CAS PubMed Google Scholar
• Klein, A. P., Hruban, R. H., Brune, K. A., Petersen, G. M. & Goggins, M. Familial pancreatic cancer. Cancer J. 7, 266–273 (2001).
  CAS PubMed Google Scholar
• Falk, R. T., Pickle, L. W., Fontham, E. T., Correa, P. & Fraumeni, J. F. Life-style risk factors for pancreatic cancer in Louisiana: a case-control study. Am. J. Epidemiol. 128, 324–336 (1988).
  Article CAS Google Scholar
• Friedman, G. D. & Van Den Eeden, S. K. Risk factors for pancreatic cancer: an exploratory study. Int. J. Epidemiol. 22, 30–37 (1993).
  Article CAS Google Scholar
• Fernandez, E., La Vecchia, C., d'Avanzo, B., Negri, E. & Franceschi, S. Family history and the risk of liver, gallbladder, and pancreatic cancer. Cancer Epidemiol. Biomarkers Prev. 3, 209–212 (1994).
  CAS PubMed Google Scholar
• Price, T. F., Payne, R. L. & Oberleitner, M. G. Familial pancreatic cancer in south Louisiana. Cancer Nurs. 19, 275–282 (1996).
  Article CAS Google Scholar
• Ghadirian, P. et al. Reported family aggregation of pancreatic cancer within a population- based case-control study in the Francophone community in Montreal, Canada. Int. J. Pancreatol. 10, 183–196 (1991).
  CAS PubMed Google Scholar
• Coughlin, S. S., Calle, E. E., Patel, A. V. & Thun, M. J. Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control 11, 915–923 (2000).
  Article CAS Google Scholar
• Schenk, M. et al. Familial risk of pancreatic cancer. J. Natl Cancer Inst. 93, 640–644 (2001).
  Article CAS Google Scholar
• Silverman, D. T. Risk factors for pancreatic cancer: a case-control study based on direct interviews. Teratog. Carcinog. Mutagen. 21, 7–25 (2001).
  Google Scholar
• Jacobs, E. J. et al. Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Int. J. Cancer 127, 1421–1428 (2010).
  Article CAS Google Scholar
• Goggins, M. et al. Use and benefits of a Web site for pancreatic cancer. JAMA 280, 1309–1310 (1998).
  Article CAS Google Scholar
• Petersen, G. M. & Hruban, R. H. Familial pancreatic cancer: where are we in 2003? J. Natl Cancer Inst. 95, 180–181 (2003).
  Article Google Scholar
• Hruban, R. H., Petersen, G. M., Ha, P. K. & Kern, S. E. Genetics of pancreatic cancer. From genes to families. Surg. Oncol. Clin. N. Am. 7, 1–23 (1998).
  Article CAS Google Scholar
• Klein, A. P. et al. Evidence for a major gene influencing risk of pancreatic cancer. Genet. Epidemiol. 23, 133–149 (2002).
  Article Google Scholar
• Bartsch, D. K. et al. Prevalence of familial pancreatic cancer in Germany. Int. J. Cancer 110, 902–906 (2004).
  Article CAS Google Scholar
• Schneider, R. et al. German national case collection for familial pancreatic cancer (FaPaCa): ten years experience. Fam. Cancer 10, 323–330 (2011).
  Article Google Scholar
• Greenhalf, W., Malats, N., Nilsson, M., Bartsch, D. & Neoptolemos, J. International registries of families at high risk of pancreatic cancer. Pancreatology 8, 558–565 (2008).
  Article Google Scholar
• Petersen, G. et al. Pancreatic cancer genetic epidemiology consortium. Cancer Epidemiol. Biomarkers Prev. 15, 704–710 (2006).
  Article Google Scholar
• James, T. A. et al. Risk factors associated with earlier age of onset in familial pancreatic carcinoma. Cancer 101, 2722–2726 (2004).
  Article Google Scholar
• Wang, L. et al. Elevated cancer mortality in the relatives of patients with pancreatic cancer. Cancer Epidemiol. Biomarkers Prev. 18, 2829–2834 (2009).
  Article Google Scholar
• Murphy, K. M. et al. Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%. Cancer Res. 62, 3789–3793 (2002).
  CAS PubMed Google Scholar
• Hahn, S. A. et al. BRCA2 germline mutations in familial pancreatic carcinoma. J. Natl Cancer Inst. 95, 214–221 (2003).
  Article CAS Google Scholar
• Couch, F. J. et al. The prevalence of BRCA2 mutations in familial pancreatic cancer. Cancer Epidemiol. Biomarkers Prev. 16, 342–346 (2007).
  Article CAS Google Scholar
• Thompson, D. & Easton, D. F. Cancer Incidence in BRCA1 mutation carriers. J. Natl Cancer Inst. 94, 1358–1365 (2002).
  Article CAS Google Scholar
• Ferrone, C. R. et al. BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma. J. Clin. Oncol. 27, 433–438 (2009).
  Article CAS Google Scholar
• Axilbund, J. E. et al. Absence of germline BRCA1 mutations in familial pancreatic cancer patients. Cancer Biol. Ther. 8, 1–5 (2009).
  Article Google Scholar
• Rutter, J. L. et al. Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control study. Cancer 101, 2809–2816 (2004).
  Article Google Scholar
• Vasen, H. F. et al. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). Int. J. Cancer 87, 809–811 (2000).
  Article CAS Google Scholar
• Kastrinos, F. et al. Risk of pancreatic cancer in families with Lynch syndrome. JAMA 302, 1790–1795 (2009).
  Article CAS Google Scholar
• van Lier, M. G. et al. High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations. Am. J. Gastroenterol. 105, 1258–1264 (2010).
  Article CAS Google Scholar
• Lowenfels, A. B. et al. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J. Natl Cancer Inst. 89, 442–446 (1997).
  Article CAS Google Scholar
• Whitcomb, D. C. et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nature Genet. 14, 141–145 (1996).
  Article CAS Google Scholar
• Whitcomb, D. C. et al. A gene for hereditary pancreatitis maps to chromosome 7q35. Gastroenterology 110, 1975–1980 (1996).
  Article CAS Google Scholar
• Witt, H. et al. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nature Genet. 25, 213–216 (2000).
  Article CAS Google Scholar
• Lowenfels, A. B., Maisonneuve, P., Whitcomb, D. C., Lerch, M. M. & DiMagno, E. P. Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA 286, 169–170 (2001).
  Article CAS Google Scholar
• Iodice, S., Gandini, S., Maisonneuve, P. & Lowenfels, A. B. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch. Surg. 393, 535–545 (2008).
  Article Google Scholar
• Chari, S. T. et al. Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology 129, 504–511 (2005).
  Article Google Scholar
• Arslan, A. A. et al. Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch. Intern. Med. 170, 791–802 (2010).
  Article Google Scholar
• Lucenteforte, E. et al. Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann. Oncol. 23, 374–382 (2012).
  Article CAS Google Scholar
• Suarez, B. K. Hampe, G. L. & Van Eerdewegh, P. in Genetic Approaches to Mental Disorders (eds Gershon, E.S. & Cloning, C. R.) 23–46 (Amereican Psyscological Association, 1994).
  Google Scholar
• Rahman, N. et al. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nature Genet. 39, 165–167 (2007).
  Article CAS Google Scholar
• Tischkowitz, M. D. et al. Analysis of the gene coding for the BRCA2-interacting protein PALB2 in familial and sporadic pancreatic cancer. Gastroenterology 137, 1183–1186 (2009).
  Article Google Scholar
• Slater, E. P. et al. PALB2 mutations in European familial pancreatic cancer families. Clin. Genet. 78, 490–494 (2010).
  Article CAS Google Scholar
• Claus, E. B., Risch, N. J. & Thompson, W. D. Age at onset as an indicator of familial risk of breast cancer. Am. J. Epidemiol. 131, 961–972 (1990).
  Article CAS Google Scholar
• Gail, M. H. et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J. Natl Cancer Inst. 81, 1879–1886 (1989).
  Article CAS Google Scholar
• Chen, S., Wang, W., Broman, K. W., Katki, H. A. & Parmigiani, G. BayesMendel: and R Environment for Mendelian Risk Prediction. Stat. Appl. Genet. Mol. Biol. 3, 21 (2004).
  Article Google Scholar
• Wang, W. et al. PancPRO: risk assessment for individuals with a family history of pancreatic cancer. J. Clin. Oncol. 25, 1417–1422 (2007).
  Article Google Scholar
• Yachida, S. et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114–1117 (2010).
  Article CAS Google Scholar
• Gold, D. V. et al. PAM4 enzyme immunoassay alone and in combination with CA 19–19 for the detection of pancreatic adenocarcinoma. Cancer 16 Aug 2012 (doi:10.1002/cncr.27762).
• Canto, M. I. et al. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 142, 796–804 (2012). This is currently the largest published study of early detection screening in individuals at a high risk of pancreatic cancer owing to the family history.
  Article Google Scholar
• Kelly, K. A. et al. Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma. PLoS Med. 5, e85 (2008).
  Article Google Scholar
• Canto, M. I. et al. Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin. Gastroenterol. Hepatol 2, 606–621 (2004).
  Article Google Scholar
• Brentnall, T. A., Bronner, M. P., Byrd, D. R., Haggitt, R. C. & Kimmey, M. B. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann.Intern.Med. 131, 247–255 (1999).
  Article CAS Google Scholar
• Bryant, H. E. et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434, 913–917 (2005).
  Article CAS Google Scholar
• McCabe, N. et al. BRCA2-deficient CAPAN-1 cells are extremely sensitive to the inhibition of Poly (ADP-Ribose) polymerase: an issue of potency. Cancer Biol. Ther. 4, 934–936 (2005).
  Article CAS Google Scholar
• van der Heijden, M. S. et al. In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor. Clin. Cancer Res. 11, 7508–7515 (2005).
  Article CAS Google Scholar
• Tutt, A. et al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial. Lancet 376, 235–244 (2010).
  Article CAS Google Scholar
• Villarroel, M. C. et al. Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer. Mol. Cancer Ther. 10, 3–8 (2010).
  Article Google Scholar
• Howes, N. et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin. Gastroenterol. Hepatol. 2, 252–261 (2004).
  Article CAS Google Scholar